Israel Englander Abbott Laboratories Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $27.6 Million - $30.8 Million	-274,300 Reduced 36.61%	474,900 $49.3 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $20.1 Million - $22.2 Million	183,300 Added 32.39%	749,200 $85.2 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $4.45 Million - $5.44 Million	-49,300 Reduced 8.01%	565,900 $62.3 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $9.2 Million - $10.3 Million	91,300 Added 17.43%	615,200 $67.1 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $25 Million - $29.5 Million	-258,600 Reduced 33.05%	523,900 $53.1 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $14.2 Million - $16.7 Million	149,400 Added 23.6%	782,500 $85.9 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $30.9 Million - $35.8 Million	319,200 Added 101.69%	633,100 $61.3 Million

3,177

1.33B

8.62M

7.18M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.